Jonathan Wang

Jonathan Wang is the Founder, Chairman, and CEO of Inmagene Biopharmaceuticals, a global clinical-stage biotechnology company focused on developing novel therapeutics for immunological and inflammatory diseases. Prior to this role, Jonathan held positions as a Venture Partner and Partner at OrbiMed, as well as Chairman at AngelAlign. Jonathan holds an MBA from Stanford University Graduate School of Business and a Ph.D. in Neurobiology and Behavior from Columbia University Vagelos College of Physicians and Surgeons.